Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain

Biological Chemistry

Volumn 387, Issue 10-11, 2006, Pages 1503-1511

  Rückrich, Thomas ^a   Brandenburg, Jens ^a   Cansier, Alexander ^a,d   Müller, Margret ^a   Stevanović, Stefan ^a   Schilling, Klaus ^b   Wiederanders, Bernd ^b   Beck, Alexander ^a   Melms, Arthur ^c   Reich, Michael ^a   Driessen, Christoph ^a   Kalbacher, Hubert ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d Panatecs GmbH   (Germany)

Author keywords

Antigen processing; Cathepsin S; Electrospray mass spectrometry; Invariant chain; MHC class II; Substrate specificity

Indexed keywords

CATHEPSIN S; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE LIBRARY;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; CONFERENCE PAPER; ENZYME ACTIVE SITE; ENZYME ASSAY; ENZYME SPECIFICITY; IMMUNOCYTOCHEMISTRY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 33750615252     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.188     Document Type: Conference Paper

References (34)

1. Beck, H., Schwarz, G., Schröter, C.J., Deeg, M., Baier, D., Stevanović, S., Weber, E., Driessen, C., and Kalbacher, H. (2001). Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur. J. Immunol. 31, 3726-3736.
2. Brömme, D., Steinert, A., Friebe, S., Fittkau, S., Wiederanders, B., and Kirschke, H. (1989). The specificity of bovine spleen cathepsin S. Biochem. J. 264, 475-481.
3. Brömme, D., Bonneau, P.R., Lachance, P., and Storer, A.C. (1994). Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity. J. Biol. Chem. 269, 30238-30242.
4. Burster, T., Beck, A., Tolosa, E., Marin-Esteban, V., Rötzschke, O., Falk, K., Lautwein, A., Reich, M., Brandenburg, J., Schwarz, G., et al. (2004). Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes. J. Immunol. 172, 5495-5503.
5. Cresswell, P. (1996). Invariant chain structure and MHC class II function. Cell 84, 505-507.
6. Fiebiger, E., Meraner, P., Weber, E., Fang, I.-F., Stingl, G., Ploegh, H., and Maurer, D. (2001). Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J. Exp. Med. 193, 881-892.
7. Greenbaum, D., Medzihradszky, K.F., Burlingame, A., and Bogyo, M. (2000). Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol. 7, 569-581.
8. Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., van Endert, P., and Amigorena, S. (2003). ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425, 397-402.
9. Harris, J.L., Backes, B.J., Leonetti, F., Mahrus, S., Ellman, J.A., and Craik, C.S. (2000). Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc. Natl. Acad. Sci. USA 97, 7754-7759.
10. Honey, K. and Rudensky, A.Y. (2003). Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. 3, 472-482.
11. Hsieh, C.-S., deRoos, P., Honey, K., Beers, C., and Rudensky, A. (2002). A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation. J. Immunol. 168, 2618-2625.
12. Lautwein, A., Burster, T., Lennon-Duménil, A.-M., Overkleeft, H.S., Weber, E., Kalbacher, H., and Driessen, C. (2002). Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells. Eur. J. Immunol. 32, 3348-3357.
13. Lautwein, A., Kraus, M., Reich, M., Burster, T., Brandenburg, J., Overkleeft, H.S., Schwarz, G., Kammer, W., Weber, E., Kalbacher, H., et al. (2004). Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S independent manner. J. Leukoc. Biol. 75, 844-855.
14. Lennon-Duménil, A.-M., Bakker, A.M., Wolf-Bryant, P., Ploegh, H.L., and Lagaudrière-Gesbert, C. (2002a). A closer look at proteolysis and MHC class II-restricted antigen presentation. Curr. Opin. Immunol. 14, 15-21.
15. Lennon-Duménil, A.-M., Bakker, A.H., Maehr, R., Fiebiger, E., Overkleeft, H.S., Rosemblatt, M., Ploegh, H.L., and Lagaudrière-Gesbert, C. (2002b). Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J. Exp. Med. 196, 529-539.
16. Manoury, B., Hewitt, E.W., Morrice, N., Dando, P.M., Barrett, A.J., and Watts, C. (1998). An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 396, 695-699.
17. McGrath, M.E., Palmer, J.T., Brömme, D., and Somoza, J.R. (1998). Crystal structure of human cathepsin S. Protein Sci. 7, 1294-1302.
18. Nakagawa, T.Y. and Rudensky, A.Y. (1999). The role of lysosomal proteases in MHC class II-mediated antigen processing and presentation. Immunol. Rev. 172, 121-129.
19. Neumann, J., Schach, N., and Koch, N. (2001). Glycosylation signals that separate the trimerization from the MHC class II-binding domain control intracellular degradation of invariant chain. J. Biol. Chem. 276, 13469-13475.
20. Pauly, T.A., Sulea, T., Ammirati, M., Sivaraman, J., Danley, D.E., Griffor, M.C., Kamath, A.V., Wang, I.-K., Laird, E.R., Seddon, A.P., et al. (2003). Specificity determinants of human cathepsin S revealed by crystal structures of complexes. Biochemistry 42, 3203-3213.
21. Plüger, E.B.E., Boes, M., Alfonso, C., Schröter, C.J., Kalbacher, H., Ploegh, H.L., and Driessen, C. (2002). Specific role for cathepsin S in the generation of antigenic peptides in vivo. Eur. J. Immunol. 32, 467-476.
22. Reimann, J. and Schirmbeck, R. (1999). Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation, Immunol. Rev. 172, 131-152.
23. Riese, R.J., Wolf, P.R., Brömme, D., Natkin, L.R., Villadangos, J.A., Ploegh, H.L., and Chapman, H.A. (1996). Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4, 357-366.
24. Saegusa, K., Ishimaru, N., Yanagi, K., Arakaki, R., Ogawa, K., Saito, I., Katunuma, N., and Hayashi, Y. (2002). Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J. Clin. Invest. 110, 361-369.
25. Schechter, I. and Berger, A. (1968). On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
26. Shen, L., Sigal, L.J., Boes, M., and Rock, K.L. (2004). Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 21, 155-165.
27. Thurmond, R.L., Sun, S., Sehon, C.A., Baker, S.M., Cai, H., Gu, Y., Jiang, W., Riley, J.P., Williams, K.N., Edwards, J.P., and Karlsson, L. (2005). Identification of a potent and selective noncovalent cathepsin S inhibitor. J. Pharmacol. Exp. Ther. 308, 268-276.
28. Tolosa, E., Li, W., Yasuda, Y., Wienhold, W., Denzin, L.K., Lautwein, A., Driessen, C., Schnorrer, P., Weber, E., Stevanović, S., et al. (2003). Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J. Clin. Invest. 112, 517-526.
29. Trombetta, E.S., Ebersold, M., Garrett, W., Pypaert, M., and Mellman, I. (2003). Activation of lysosomal function during dendritic cell maturation. Science 299, 1400-1403.
30. Turk, V., Turk, B., and Turk, D. (2001). Lysosomal cysteine proteases: facts and opportunities. EMBO J. 20, 4629-4633.
31. Van Swieten, P.F., Maehr, R., Van Den Nieuwendijk, A.M., Kessler, B.M., Reich, M., Wong, C.S., Kalbacher, H., Leeuwenburgh, M.A., Driessen, C., Van Der Marel, G.A., et al. (2004). Development of an isotope-coded activity-based probe for the quantitative profiling of cysteine proteases. Bioorg. Med. Chem. Lett. 14, 3131-3134.
32. Villadangos, J.A., Riese, R.J., Peters, C., Chapman, H.A., and Ploegh, H.L. (1997). Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J. Exp. Med. 186, 549-560.
33. Villadangos, J.A., Bryant, R.A.R., Deussing, J., Driessen, C., Lennon-Duménil, A.-M., Riese, R.J., Roth, W., Saftig, P., Shi, G.-P., Chapman, H.A., et al. (1999). Proteases involved in MHC class II antigen presentation. Immunol. Rev. 172, 109-120.
34. Yang, H., Kala, M., Scott, B.J., Goluszko, E., Chapman, H.A., and Christadoss, P. (2005). Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis. J. Immunol. 174, 1729-1737.